View in EDS

Venous thromboembolism risk for patients with BMI ≥40 kg/m2 undergoing robotic surgery for endometrial cancer.

Saved in:
Bibliographic Details
Title: Venous thromboembolism risk for patients with BMI ≥40 kg/m2 undergoing robotic surgery for endometrial cancer.
Authors: Dinkins KG; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States., Lee GM; Department of Obstetrics and Gynecology, University of Alabama at Birmingham Birmingham, Alabama, United States., Ketch PW; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States., Toboni MD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States., Leath CA 3rd; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States., Straughn JM Jr; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States., Boitano TKL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States.
Source: Gynecologic oncology reports [Gynecol Oncol Rep] 2025 Jun 09; Vol. 59, pp. 101779. Date of Electronic Publication: 2025 Jun 09 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101652231 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5789 (Print) Linking ISSN: 23525789 NLM ISO Abbreviation: Gynecol Oncol Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-5789
DOI:10.1016/j.gore.2025.101779